Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular network-selected pharmacogenomics in a case of bipolar spectrum disorder.

Pharmacogenomics - 1 Dec 2017

Fortinguerra Stefano, Buriani Alessandro, Sorrenti Vincenzo, Lenzi Michele, Giusti Pietro

Abstract excerpt

Personal genomic analysis was used for molecular diagnosis and pharmacogenomics in a 53-year-old female suffering from alternating depressive and dysphoric episodes. A total of 52 genes and 108 SNPs were analyzed in the whole genome. Results from the pharmacogenomic analysis were consistent with the pharmacological history and indicate mutations associated with low monoaminergic tone, but also a hyperactive 5HT2A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents, Tricyclic
Share to Bipolar Disorder

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depressive Disorder, Major

Share to Genomics

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Share to Serotonin

Source

Identifiers

PMID: 29173093
DOI: 10.2217/pgs-2017-0133

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular network-selected pharmacogenomics in a case of bipolar spectrum disorder.PMID 29173093Read ↗

Pharmacogenomics in psychiatry: from therapeutic drug monitoring to genomic medicine.Semantic proximity Read ↗

Genetic Variations Associated with Long-Term Treatment Response in Bipolar Depression.Semantic proximity Read ↗

Genomics of Bipolar Disorder: What the Clinician Needs to Know.Semantic proximity Read ↗

Pharmacogenomic aspects of bipolar disorder: An updateSemantic proximity Read ↗

Leveraging the Genetics of Psychiatric Disorders to Prioritize Potential Drug Targets and CompoundsSemantic proximity Read ↗

In silico analysis predicts mutational consequences of CITED2, NUDT4, and Ar18B in patients with bipolar disorder.Semantic proximity Read ↗

Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selectionSemantic proximity Read ↗

Personalized medicine in psychiatry: new technologies and approaches.Semantic proximity Read ↗

Pharmacogenomics of Bipolar DisorderSemantic proximity Read ↗

Genetics and personalized medicine in antidepressant treatment.Semantic proximity Read ↗

Genetics and Antiepileptic Mood Stabilizer Treatment Response in Bipolar Disorder: What do we Know?Semantic proximity Read ↗

The search for personalized antidepressant treatments: what have we learned and where are we going.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.